CTLA4 and neoplasm: As an alternative to a T cell‐directed mechanism of action, as PD‐1 and CTLA‐4 are also expressed on B cells and some myeloid cells, and PD‐L1 on neurons and tumor cells, the checkpoint inhibitors may have additional direct actions via other cell types.2 These mechanisms should be investigated in future studies.